Nucleic Acid Pharmaceuticals Utilizing microRNA (miRNA) Market Outlook 2026-2038

The global nucleic acid pharmaceuticals utilizing microRNA market size was valued at USD 598.38 million in 2025 and is projected to reach USD 5.23 billion by the end of 2038, rising at a CAGR of 18.12% during the forecast period (2026-2038). In 2026, the industry size of nucleic acid pharmaceuticals utilizing microRNA is expected to be USD 708.56 million. The growing demand for nucleic acid pharmaceuticals utilizing microRNA in cancer treatment is fueling market growth.

1. An Outline of the Global Nucleic Acid Pharmaceuticals Utilizing microRNA Market

1.1. Market Definition and Segmentation
1.2. Study Assumptions and Abbreviations

2. Research Methodology & Approach

2.1. Primary Research
2.2. Secondary Research
2.3. Data Triangulation
2.4. SPSS Methodology

3. Executive Summary4. Growth Drivers5. Major Roadblocks6. Opportunities7. Prevalent Trends8. Government Regulation9. Growth Outlook10. Competitive White Space Analysis - Identifying Untapped Market Gaps11. Risk Overview12. SWOT13. Technological Advancement14. Technology Maturity Matrix for Nucleic Acid Pharmaceuticals Utilizing microRNA15. Recent News16. Regional Demand17. Global Nucleic Acid Pharmaceuticals Utilizing microRNA by Geography - Strategic Comparative Analysis18. Strategic Segment Analysis: Nucleic Acid Pharmaceuticals Utilizing microRNA Demand Landscape19. Global Nucleic Acid Pharmaceuticals Utilizing microRNA Demand Trends Driven by Prevalence of Cardiovascular Diseases, Advancement in Neuro Research and Cancer Care 2026-2038)20. Root Cause Analysis (RCA) for discovering problems of the Nucleic Acid Pharmaceuticals Utilizing microRNA Porter Five Forces21. PESTLE22. Comparative Positioning23. Automotive Aftermarket Fuel Additive- Key Player Analysis (2038)24. Competitive Landscape: Key Suppliers/Players25. Competitive Model: A Detailed Inside View for Investors

26. Company Market Share, 2038 (%)

26.1. Business Profile of Key Enterprise
26.1.1. Regulus Therapeutics Inc.
26.1.2. Viridian Therapeutics
26.1.3. Silence Therapeutics plc
26.1.4. Synlogic, Inc.
26.1.5. Alnylam Pharmaceuticals, Inc
26.1.6. AstraZeneca plc
26.1.7. Novartis AG
26.1.8. Moderna, Inc
26.1.9. BioNTech SE
26.1.10. InteRNA Technologies B.V.
26.1.11. Thermo Fisher Scientific Inc.

27. Global Nucleic Acid Pharmaceuticals Utilizing microRNA Market Outlook

27.1. Market Overview
27.1.1. Market Revenue by Value (USD Million), Volume (Million Tons), and Compound Annual Growth Rate (CAGR)
27.2. Global Segmentation Nucleic Acid Pharmaceuticals Utilizing microRNA Analysis (2026-2038)
27.2.1. By Product Type
27.2.1.1. miRNA Mimics, Market Value (USD Million), and CAGR, 2026-2038F
27.2.1.2. miRNA Inhibitors [Antagomiers], Market Value (USD Million), and CAGR, 2026-2038F
27.2.1.3. miRNA Sponges, Market Value (USD Million), and CAGR, 2026-2038F
27.2.1.4. Others, Market Value (USD Million), and CAGR, 2026-2038F
27.2.2. By Application
27.2.2.1. Oncology, Market Value (USD Million), and CAGR, 2026-2038F
27.2.2.2. Cardiovascular Diseases, Market Value (USD Million), and CAGR, 2026-2038F
27.2.2.3. Neurological Disorders, Market Value (USD Million), and CAGR, 2026-2038F
27.2.2.4. Infectious Diseases, Market Value (USD Million), and CAGR, 2026-2038F
27.2.2.5. Others, Market Value (USD Million), and CAGR, 2026-2038F
27.2.3. By End user
27.2.3.1. Pharmaceutical & Biotechnology Companies, Market Value (USD Million), and CAGR, 2026-2038F
27.2.3.2. Academics & Research Institutes, Market Value (USD Million), and CAGR, 2026-2038F
27.2.3.3. Contract Research Organization, Market Value (USD Million), and CAGR, 2026-2038F
27.2.3.4. Others, Market Value (USD Million), and CAGR, 2026-2038F
27.2.4. By Delivery Technology
27.2.4.1. Lipid Nanoparticles Market Value (USD Million), and CAGR, 2026-2038F
27.2.4.2. Polymeric Nanoparticles, Market Value (USD Million), and CAGR, 2026-2038F
27.2.4.3. Exosomes, Market Value (USD Million), and CAGR, 2026-2038F
27.2.4.4. Others, Market Value (USD Million), and CAGR, 2026-2038F
27.2.5. Regional Synopsis, Value (USD Million), 2026-2038
27.2.5.1. North America Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2038F
27.2.5.2. Europe Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2038F
27.2.5.3. Asia-Pacific Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2038F
27.2.5.4. Latin America Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2038F
27.2.5.5. Middle East and Africa Market Value (USD Million) and CAGR & Y-o-Y Growth Trend, 2026-2038F

28. North America Market29. Europe Market30. Asia-Pacific Market31. Latin America Market32. Middle East & Africa Market33. Global Economic Scenario34. About the Analyst

Companies Mentioned

Regulus Therapeutics Inc. (U.S.)
Viridian Therapeutics (U.S.)
Silence Therapeutics plc (UK)
Synlogic Inc. (U.S.)
Alnylam Pharmaceuticals Inc. (U.S.)
AstraZeneca plc (UK)
Novartis AG (Switzerland)
Moderna Inc. (U.S.)
BioNTech SE (Germany)
InteRNA Technologies B.V. (Netherlands)
Thermo Fisher Scientific Inc. (U.S.)
GeneCopoeia Inc. (U.S.)

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4904EUR$5,550USD£4,245GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5787EUR$6,550USD£5,009GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€9321EUR$10,550USD£8,069GBP

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Nucleic Acid Therapeutics Market Report 2026

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report 2026

siRNA/miRNA Synthesis Service Market - Global Forecast 2025-2030

Small Nucleic Acid Therapies Market - Global Forecast 2025-2032

MicroRNA Market - Forecast from 2026 to 2031